Document is current
Any future updates will be listed below
-
Authors
Du, Mengxi https://orcid.org/0000-0002-6406-7250
Drew, David A.
Goncalves, Marcus D. https://orcid.org/0000-0002-0784-9248
Cao, Yin https://orcid.org/0000-0001-9835-7662
Chan, Andrew T. https://orcid.org/0000-0001-7284-6767
- License Information
-
More Information
Article History
Accepted: 15 July 2025
First Online: 8 August 2025
Competing interests
: M.D.G. holds equity in Faeth Therapeutics and Skye Biosciences; reports consulting or advisory roles with Almac Discovery, Genentech Inc., Faeth Therapeutics, Scorpion Therapeutics and Skye Biosciences; and patents, royalties and other intellectual property with Weill Cornell Medicine and Faeth Therapeutics. Y.C. has served as a consultant for Need Inc. and Geneocopy Inc. A.T.C. serves as a consultant for Pfizer Inc. and Boehringer Ingelheim. All of the above disclosures are outside of the submitted work. The other authors declare no competing interests.
